Literature DB >> 26194978

Cascade Screening in Familial Hypercholesterolemia: Advancing Forward.

Raul D Santos1, Thiago S Frauches, Ana P M Chacra.   

Abstract

Familial hypercholesterolemia is a genetic disorder associated with elevated LDL-cholesterol and high lifetime cardiovascular risk. Both clinical and molecular cascade screening programs have been implemented to increase early definition and treatment. In this systematic review, we discuss the main issues found in 65 different articles related to cascade screening and familial hypercholesterolemia, covering a range of topics including different types/strategies, considerations both positive and negative regarding cascade screening in general and associated with the different strategies, cost and coverage consideration, direct and indirect contact with patients, public policy around life insurance and doctor-patient confidentiality, the "right to know," and public health concerns regarding familial hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26194978     DOI: 10.5551/jat.31237

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  5 in total

Review 1.  The panorama of familial hypercholesterolemia in Latin America: a systematic review.

Authors:  Roopa Mehta; Rafael Zubirán; Alexandro J Martagón; Alejandra Vazquez-Cárdenas; Yayoi Segura-Kato; María Teresa Tusié-Luna; Carlos A Aguilar-Salinas
Journal:  J Lipid Res       Date:  2016-10-24       Impact factor: 5.922

Review 2.  Challenges faced by patients with dyslipidemia and systemic arterial hypertension in Brazil: a design of the patient journey.

Authors:  Jose Rocha Faria-Neto; Carlos Yarleque; Luiz Fernando Vieira; Eliane Naomi Sakane; Raul D Santos
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

Review 3.  Familial Hypercholesterolemia: Advances in Recognition and Therapy.

Authors:  Jacqueline L Cartier; Anne Carol Goldberg
Journal:  Prog Cardiovasc Dis       Date:  2016-07-29       Impact factor: 8.194

Review 4.  Familial Screening for Left-Sided Congenital Heart Disease: What Is the Evidence? What Is the Cost?

Authors:  Daniel J Perry; Connor R Mullen; Horacio G Carvajal; Anoop K Brar; Pirooz Eghtesady
Journal:  Diseases       Date:  2017-12-08

5.  Guidance for Pediatric Familial Hypercholesterolemia 2017.

Authors:  Mariko Harada-Shiba; Takao Ohta; Akira Ohtake; Masatsune Ogura; Kazushige Dobashi; Atsushi Nohara; Shizuya Yamashita; Koutaro Yokote
Journal:  J Atheroscler Thromb       Date:  2018-02-06       Impact factor: 4.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.